Bluestein R H & CO LLC Novo Nordisk A S Transaction History

Bluestein R H & CO LLC

$1.61 Billion
Q3 2022

A detailed history of Bluestein R H & CO LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Bluestein R H & CO LLC holds 10,100 shares of NVO stock, worth $858,500. This represents 0.06% of its overall portfolio holdings.

Number of Shares

10,100

Previous 11,000 8.18%

Holding current value

$858,500

Previous $1.23 Million 17.94%

% of portfolio

0.06%

Previous 0.08%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$95.28 - $116.93 $85,752 - $105,237	-900 Reduced 8.18%	10,100 $1.01 Million
Q2 2022 Aug 11, 2022	SELL	$103.24 - $121.81 $722,680 - $852,670	-7,000 Reduced 38.89%	11,000 $1.23 Million
Q1 2022 May 11, 2022	BUY	$93.1 - $112.54 $74,480 - $90,032	800 Added 4.65%	18,000 $2 Million
Q4 2021 Feb 14, 2022	SELL	$95.88 - $117.08 $383,520 - $468,320	-4,000 Reduced 18.87%	17,200 $1.93 Million
Q2 2021 Aug 13, 2021	BUY	$67.66 - $84.76 $47,362 - $59,332	700 Added 3.41%	21,200 $1.78 Million
Q1 2021 May 12, 2021	BUY	$67.06 - $75.82 $704,130 - $796,109	10,500 Added 105.0%	20,500 $1.38 Million
Q4 2020 Feb 12, 2021	SELL	$63.89 - $73.8 $319,450 - $369,000	-5,000 Reduced 33.33%	10,000 $699,000
Q3 2019 Nov 13, 2019	SELL	$47.54 - $53.43 $142,620 - $160,290	-3,000 Reduced 16.67%	15,000 $776,000
Q4 2018 Feb 13, 2019	SELL	$41.54 - $47.25 $83,080 - $94,500	-2,000 Reduced 10.0%	18,000 $829,000
Q3 2017 Nov 13, 2017	BUY	$41.15 - $49.22 $823,000 - $984,400	20,000	20,000 $963,000

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $192B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bluestein R H & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bluestein R H & CO LLC with notifications on news.

Account

Bluestein R H & CO LLC Novo Nordisk A S Transaction History